Patent ID: 11897852
Assignee: THE UNIVERSITY OF TOLEDO
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. A method of treating a mammalian patient in need thereof, the method comprising:
administering induced stem cells to a mammalian patient in need thereof;
wherein the induced stem cells are derived from incubating stem cells with a pharmaceutical composition comprising a peroxisome proliferator activated receptor (PPAR) compound in an amount sufficient to prompt stem cells in the patient to contribute toward improving cartilage health and inducing chondrogenesis, and a pharmaceutically acceptable carrier, excipient, diluent or adjuvant;
wherein the PPAR compound has a chemical structure of Formula (12d):, , wherein:
X is S;
R1 is CF3;
R2 is F; and
R3 is H; and,
salts, isomers, solvates, hydrates, polymorphs and prodrugs thereof.